Time delays in the diagnosis and treatment of Fabry disease

Effectiveness of agalsidase alfa enzyme replacement in Fabry disease: cardiac outcomes after 10 years’ treatment

(2015) Christoph Kampmann et al.   Orphanet Journal of Rare Diseases

Enzyme Replacement Therapy Stabilized White Matter Lesion Progression in Fabry Disease

(2014) Andreas Fellgiebel et al.   CEREBROVASCULAR DISEASES

Therapeutic goals in the treatment of Fabry disease

(2010) Atul Mehta et al.   GENETICS IN MEDICINE

Effects of enzyme replacement therapy in Fabry disease—A comprehensive review of the medical literature

(2010) Olivier Lidove et al.   GENETICS IN MEDICINE

Agalsidase Alfa and Kidney Dysfunction in Fabry Disease

(2009) M. West et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Enzyme replacement therapy with agalsidase alfa in patients with Fabry's disease: an analysis of registry data

(2009) A Mehta et al.   LANCET

Diagnosis of Fabry Disease via Analysis of Family History

(2008) Dawn A. Laney et al.   Journal of Genetic Counseling

Effects of enzyme replacement therapy on the cardiomyopathy of Anderson Fabry disease: a randomised, double-blind, placebo-controlled clinical trial of agalsidase alfa

(2007) D A Hughes et al.   HEART